Clinical efficacy of early continuous subcutaneous insulin infusion combined with sitagliptin in treatment of patients with primary diagnosed T2DM and its influencing factors

YAN Tao

doi:10.7619/jcmp.201513004

YAN Tao. Clinical efficacy of early continuous subcutaneous insulin infusion combined with sitagliptin in treatment of patients with primary diagnosed T2DM and its influencing factors[J]. Journal of Clinical Medicine in Practice, 2015, (13): 12-15. DOI: 10.7619/jcmp.201513004

Citation:

YAN Tao. Clinical efficacy of early continuous subcutaneous insulin infusion combined with sitagliptin in treatment of patients with primary diagnosed T2DM and its influencing factors[J]. Journal of Clinical Medicine in Practice, 2015, (13): 12-15. DOI: 10.7619/jcmp.201513004

Citation:

YAN Tao. Clinical efficacy of early continuous subcutaneous insulin infusion combined with sitagliptin in treatment of patients with primary diagnosed T2DM and its influencing factors[J]. Journal of Clinical Medicine in Practice, 2015, (13): 12-15. DOI: 10.7619/jcmp.201513004

Clinical efficacy of early continuous subcutaneous insulin infusion combined with sitagliptin in treatment of patients with primary diagnosed T2DM and its influencing factors

YAN Tao

Graphical Abstract

Abstract

FullText(HTML)

References (0)

Clinical efficacy of early continuous subcutaneous insulin infusion combined with sitagliptin in treatment of patients with primary diagnosed T2DM and its influencing factors

Catalog

Export File

Citation

Format

Content